Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma

NCT01064648 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

117

Enrollment

NIH

Sponsor class

Conditions

Epithelioid Mesothelioma
Pleural Malignant Mesothelioma
Recurrent Malignant Mesothelioma
Sarcomatoid Mesothelioma

Interventions

DRUG: Cediranib Maleate
DRUG: Cisplatin
OTHER: Laboratory Biomarker Analysis
DRUG: Pemetrexed Disodium
OTHER: Placebo Administration

Sponsor

National Cancer Institute (NCI)